Back
Trevi Therapeutics, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
TRVI
Trevi Therapeutics, Inc.
Last Price:
$13.47
Seasonality Move:
49.5%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.14 | Buy |
| 20-day SMA: | 12.07 | Buy |
| 50-day SMA: | 10.98 | Buy |
| 200-day SMA: | 7.7 | Buy |
| 8-day EMA: | 13.06 | Buy |
| 20-day EMA: | 12.26 | Buy |
| 50-day EMA: | 11.06 | Buy |
| 200-day EMA: | 8.1 | Buy |
Trevi Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 69.96 | Buy |
| Chaikin Money Flow: | -269947 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.82 - 12.88) | Buy |
| Bollinger Bands (100): | (7.42 - 11.24) | Buy |
Trevi Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics, Inc. Stock
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 13.47 while TRVI 8-day simple moving average is 13.14, which is a Buy signal.
-
The stock price of TRVI is 13.47 while Trevi Therapeutics, Inc. 20-day SMA is 12.07, which makes it a Buy.
-
Trevi Therapeutics, Inc. 50-day simple moving average is 10.98 while TRVI share price is 13.47, making it a Buy technically.
-
TRVI stock price is 13.47 and Trevi Therapeutics, Inc. 200-day simple moving average is 7.70, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
61
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Is Trevi Therapeutics, Inc. a Buy or a Sell?
-
Trevi Therapeutics, Inc. stock is rated a BuyThe current Trevi Therapeutics, Inc. [TRVI] share price is $13.47. The Score for TRVI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics, Inc. Stock Info
Market Cap:
1.7B
Price in USD:
13.47
Share Volume:
2.6M
Trevi Therapeutics, Inc. 52-Week Range
52-Week High:
14.00
52-Week Low:
2.36
Buy
61
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Trevi Therapeutics, Inc. Share Price Forecast
-
What is the Trevi Therapeutics, Inc. stock price today?The Trevi Therapeutics, Inc. stock price is 13.47 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics, Inc. is not overvalued.
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 13.47 while TRVI 8-day exponential moving average is 13.06, which is a Buy signal.
-
The stock price of TRVI is 13.47 while Trevi Therapeutics, Inc. 20-day EMA is 12.26, which makes it a Buy.
-
Trevi Therapeutics, Inc. 50-day exponential moving average is 11.06 while TRVI share price is 13.47, making it a Buy technically.
-
TRVI stock price is 13.47 and Trevi Therapeutics, Inc. 200-day simple moving average is 8.10, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics, Inc.
Is Trevi Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Trevi Therapeutics, Inc.
Should I short Trevi Therapeutics, Inc. stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.76, suggesting Trevi Therapeutics, Inc. is a Buy
-
Trevi Therapeutics, Inc. Relative Strength Index (RSI) is 69.96, which suggest Trevi Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics, Inc. is (10.82 - 12.88), which suggest Trevi Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics, Inc. is (7.42 - 11.24), which suggest Trevi Therapeutics, Inc. is a Buy
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.